Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | CASP1 | P29466 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.55 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.55 |
| ▸ | LTA4H | P09960 | 2/20 | 0.54 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.54 |
| ▸ | NQO1 | P15559 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.50 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10610791 | 0.98 | KMT2A (0.58) | KMT2AMEN1USP2ALDH1A1LMNA | |
| SCHEMBL5671708 | 0.94 | LTA4H (0.61) | KMT2AMEN1USP2ALDH1A1LMNA | |
| SCHEMBL4248652 | 0.90 | NQO1 (0.67) | KMT2AMEN1USP2ALDH1A1LMNA | |
| SCHEMBL10575040 | 0.88 | NQO1 (0.64) | KMT2AMEN1USP2ALDH1A1LMNA | |
| SCHEMBL1240940 | 0.86 | NQO1 (0.61) | KMT2AMEN1USP2ALDH1A1LMNA | |
| SCHEMBL30101910 | 0.85 | ALDH1A1 (0.65) | KMT2AMEN1USP2ALDH1A1LMNA | |
| SCHEMBL12251519 | 0.84 | MAPT (0.66) | KMT2AMEN1USP2ALDH1A1LMNA | |
| SCHEMBL10570997 | 0.84 | RAB9A (0.61) | KMT2AMEN1USP2ALDH1A1LMNA | |
| SCHEMBL8521940 | 0.82 | MAPT (0.64) | KMT2AMEN1USP2ALDH1A1LMNA | |
| SCHEMBL39534 | 0.82 | MAPT (0.64) | KMT2AMEN1USP2ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12398168-B2 | Preparation method of a glycoside compound | SHANGHAI HUTCHISON PHARMACEUTICALS LIMITED (CN) | 2025-08-26 | — | — | US | disclosed |
| US-20220380399-A1 | PREPARATION METHOD OF A GLYCOSIDE COMPOUND | SHANGHAI HUTCHISON PHARMACEUTICALS LIMITED (CN) | 2022-12-01 | — | — | US | disclosed |
| WO-2021139621-A1 | METHOD FOR PREPARING GLYCOSIDE COMPOUND | 上海和黄药业有限公司 | 2021-07-15 | — | — | WO | disclosed |
| EP-0411150-B1 | INDOLE DERIVATIVES, PREPARATION THEREOF, AND DRUG FOR PREVENTING AND TREATING NEPHRITIS CONTAINING SAME | OTSUKA PHARMA CO LTD (JP) | 1996-11-27 | — | — | EP | disclosed |
| US-5459142-A | Autoimmune disease, atherosclerosis, antiischemic agents and nephritis | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1995-10-17 | — | — | US | disclosed |
| US-5238938-A | Nephrosis | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-08-24 | — | — | US | disclosed |
| EP-0411150-A1 | INDOLE DERIVATIVES, PREPARATION THEREOF, AND DRUG FOR PREVENTING AND TREATING NEPHRITIS CONTAINING SAME | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-02-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12398168-B2 | Preparation method of a glycoside compound | GALE, ST6GAL1, MGAM | KMT2A 3283/4885MEN1 1680/4885USP2 2400/4885 |
| US-20220380399-A1 | PREPARATION METHOD OF A GLYCOSIDE COMPOUND | GALE, ST6GAL1, MGAM | KMT2A 3283/4885MEN1 1680/4885USP2 2400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.